嘉和生物国际配售超购逾60倍，预计10月7日挂牌交易_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1105482182?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","is_english":false,"pubTime":"2020-09-29 10:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105482182","market":"hk","top_or_hot":-1,"title":"嘉和生物国际配售超购逾60倍，预计10月7日挂牌交易","media":"老虎资讯综合","content":"<p>9月29日讯，<a href=\"https://laohu8.com/S/06998\">嘉和生物-B</a>于今日截止招股，国际配售超购逾60倍，创欧康维视后记录。预计2020年10月7日在港交所上市。</p><p>嘉和生物（Genor Biopharma Co. Ltd）是一家领先生物制药企业， 已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出，药物制造方面也极具优势，旗下工厂拥有行业级领先生物医药生产技术。</p><p>目前，嘉和生物最大股东为高瓴资本，高瓴资本旗下的HHJH持有嘉和近35%。除此之外，明星股东还有新加坡主权基金淡马锡、<a href=\"https://laohu8.com/S/300347\">泰格医药</a>、<a href=\"https://laohu8.com/S/601318\">中国平安</a>等。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>嘉和生物国际配售超购逾60倍，预计10月7日挂牌交易</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n嘉和生物国际配售超购逾60倍，预计10月7日挂牌交易\n</h2>\n\n<h4 class=\"meta\">\n\n2020-09-29 10:37 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>9月29日讯，嘉和生物-B于今日截止招股，国际配售超购逾60倍，创欧康维视后记录。预计2020年10月7日在港交所上市。嘉和生物（Genor Biopharma Co. Ltd）是一家领先生物制药企业， 已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出，药物制造方面也极具优势，旗下工厂拥有行业级领先生物医药生产技术。目前，...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06998","symbol_name":"嘉和生物-B","start_time":0,"source_url":null,"article_id":"1105482182","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105482182","pubTimestamp":1601347079,"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"9月29日讯，嘉和生物-B于今日截止招股，国际配售超购逾60倍，创欧康维视后记录。预计2020年10月7日在港交所上市。嘉和生物（Genor Biopharma Co. Ltd）是一家领先生物制药企业","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06998":"嘉和生物-B"},"translate_title":"Jiahe Biology International Placement has exceeded the purchase by more than 60 times and is expected to be listed for trading on October 7.","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/8b89d9ecd9871b363cd9b9901a5a7542","symbols_score_info":{"06998":0.9},"content_text":"9月29日讯，嘉和生物-B于今日截止招股，国际配售超购逾60倍，创欧康维视后记录。预计2020年10月7日在港交所上市。嘉和生物（Genor Biopharma Co. Ltd）是一家领先生物制药企业， 已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出，药物制造方面也极具优势，旗下工厂拥有行业级领先生物医药生产技术。目前，嘉和生物最大股东为高瓴资本，高瓴资本旗下的HHJH持有嘉和近35%。除此之外，明星股东还有新加坡主权基金淡马锡、泰格医药、中国平安等。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":974772572,"gmtCreate":1601349725996,"gmtModify":1703824024716,"author":{"id":"3557447708424107","authorId":"3557447708424107","name":"曼妮小姐","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3557447708424107","authorIdStr":"3557447708424107"},"htmlText":"希望一手能中","listText":"希望一手能中","text":"希望一手能中","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/974772572","repostId":1105482182,"repostType":4,"repost":{"id":"1105482182","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1601347079,"share":"https://www.laohu8.com/m/news/1105482182?lang=&edition=full","pubTime":"2020-09-29 10:37","market":"hk","language":"zh","title":"嘉和生物国际配售超购逾60倍，预计10月7日挂牌交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1105482182","media":"老虎资讯综合","summary":"9月29日讯，嘉和生物-B于今日截止招股，国际配售超购逾60倍，创欧康维视后记录。预计2020年10月7日在港交所上市。嘉和生物（Genor Biopharma Co. Ltd）是一家领先生物制药企业","content":"<p>9月29日讯，<a href=\"https://laohu8.com/S/06998\">嘉和生物-B</a>于今日截止招股，国际配售超购逾60倍，创欧康维视后记录。预计2020年10月7日在港交所上市。</p><p>嘉和生物（Genor Biopharma Co. Ltd）是一家领先生物制药企业， 已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出，药物制造方面也极具优势，旗下工厂拥有行业级领先生物医药生产技术。</p><p>目前，嘉和生物最大股东为高瓴资本，高瓴资本旗下的HHJH持有嘉和近35%。除此之外，明星股东还有新加坡主权基金淡马锡、<a href=\"https://laohu8.com/S/300347\">泰格医药</a>、<a href=\"https://laohu8.com/S/601318\">中国平安</a>等。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>嘉和生物国际配售超购逾60倍，预计10月7日挂牌交易</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n嘉和生物国际配售超购逾60倍，预计10月7日挂牌交易\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-09-29 10:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>9月29日讯，<a href=\"https://laohu8.com/S/06998\">嘉和生物-B</a>于今日截止招股，国际配售超购逾60倍，创欧康维视后记录。预计2020年10月7日在港交所上市。</p><p>嘉和生物（Genor Biopharma Co. Ltd）是一家领先生物制药企业， 已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出，药物制造方面也极具优势，旗下工厂拥有行业级领先生物医药生产技术。</p><p>目前，嘉和生物最大股东为高瓴资本，高瓴资本旗下的HHJH持有嘉和近35%。除此之外，明星股东还有新加坡主权基金淡马锡、<a href=\"https://laohu8.com/S/300347\">泰格医药</a>、<a href=\"https://laohu8.com/S/601318\">中国平安</a>等。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","relate_stocks":{"06998":"嘉和生物-B"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105482182","content_text":"9月29日讯，嘉和生物-B于今日截止招股，国际配售超购逾60倍，创欧康维视后记录。预计2020年10月7日在港交所上市。嘉和生物（Genor Biopharma Co. Ltd）是一家领先生物制药企业， 已成功研发出靶向通路极具潜力的候选药物，涵盖全球前三大肿瘤靶点及前十款畅销药物中的五款。嘉禾不仅在药物研发方面表现突出，药物制造方面也极具优势，旗下工厂拥有行业级领先生物医药生产技术。目前，嘉和生物最大股东为高瓴资本，高瓴资本旗下的HHJH持有嘉和近35%。除此之外，明星股东还有新加坡主权基金淡马锡、泰格医药、中国平安等。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":2898141,"gmtCreate":1601349922510,"gmtModify":1601349922510,"authorId":3527667803686145,"author":{"id":3527667803686145,"idStr":"3527667803686145","authorId":3527667803686145,"name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":974772572,"type":1,"supId":0,"prevId":0,"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}

嘉和生物国际配售超购逾60倍，预计10月7日挂牌交易

评论（1）

热议股票

7x24